Dr. Erik Roberson
Dr. Roberson is Professor of Neurology and Neurobiology at the University of Alabama at Birmingham (UAB), where he directs the Center for Neurodegeneration and Experimental Therapeutics and the Alzheimer’s Disease Center. He received his A.B. with highest honors from Princeton University and then earned his M.D. and Ph.D in neuroscience at Baylor College of Medicine where he studied molecular mechanisms of learning and memory. He completed a residency in neurology at the University of California San Francisco, where he also served as Chief Resident in Neurology. After residency, he completed a clinical fellowship in behavioral neurology with Dr. Bruce Miller at UCSF and resumed basic research in the laboratory of Dr. Lennart Mucke at the Gladstone Institute of Neurological Disease, initiating his current studies of neurodegenerative disease.
The Roberson lab studies the neurobiology of Alzheimer’s disease (AD) and frontotemporal dementia (FTD), with a focus on understanding the cellular and molecular mechanisms of these disorders and identifying new therapeutic strategies. The role of tau and tau-interacting proteins in AD and FTD, and approaches to treating FTD due to progranulin deficiency are major areas of interest. Dr. Roberson also cares for patients with memory disorders and dementia at the Kirklin Clinic and directs clinical research programs in AD and FTD.
- 2015 Erik Roberson Advisor Fellow: Dr. Travis Rush, Targeting the Tau-Fyn Interaction in Alzheimer’s Disease
- 2016 Erik Roberson Advisor Fellow: Dr. Travis Rush, Targeting the Tau-Fyn Interaction in Alzheimer’s Disease
- 2017 Erik Roberson Advisor Fellow: Dr. Jonathan Roth, Developing inhibitors of tau-SH3 interactions as treatments for Alzheimer’s disease and hyperexcitability